Immunomodulatory effects of low dose cis-Diaminedichloroplatinum (cisplatin) combined with UFT and PSK in patients with advanced colorectal cancer

Cancer Investigation
Masahiko ShibataMasahiro Fukuzawa

Abstract

It is well known that cell-mediated immunity is suppressed in patients with neoplastic diseases. We have reported that soluble receptors for interleukin-2 (sIL-2R) and tumor necrosis factor (sTNF-R1) are elevated in the serum of patients with advanced colorectal cancer. The presence of these soluble receptors and immunosuppressive cytokines, including interleukin-10 (IL-10), might be important in the mechanisms of immunosuppression. cis-Diaminedichloroplatinum (cisplatin) has been reported to immunomodulate, especially when used in low dose in combination with 5-Fluorouracil (5-FU). In this study, cisplatin and UFT, a form of uracil and tegafur which is a prodrug of 5-FU, were administered with immunomodulator Polysaccharide K (PSK) to ten patients with colorectal cancer, who showed distant metastasis in the liver or lung, and the serum levels of sIL-2R and sTNF-R1 and the production of gamma-interferon (gamma-INF) and interleukin-10 by peripheral blood mononuclear cells were measured. The serum concentrations of sIL-2R and the production of IL-10 were reduced (p < 0.05) after 2 months of treatment. Thus, this combination appeared to have immunomodulative potential in patients with advanced colorectal cancer.

References

May 1, 1992·Immunology Today·L A Tartaglia, D V Goeddel
Aug 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·P PisaR Kiessling
Jul 1, 1992·Journal of Clinical Immunology·M HowardJ de Vries
Aug 1, 1990·The Journal of Experimental Medicine·F Porteu, C Nathan
Jan 1, 1988·Immunological Reviews·C A JanewayK Bottomly
Dec 1, 1989·The Journal of Experimental Medicine·D F FiorentinoT R Mosmann
Jan 1, 1989·Annual Review of Cell Biology·K A Smith
Sep 1, 1988·Breast Cancer Research and Treatment·H NagasawaM Ishida
Nov 16, 1988·Journal of the National Cancer Institute·M S Mitchell
Jun 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·T HahnD Wallach
Jan 1, 1982·Immunological Reviews·J L Turk, D Parker
Jun 1, 1993·Immunology Today·F Powrie, R L Coffman
Feb 1, 1994·International Journal of Immunopharmacology·S YunokiK Orita
Oct 1, 1993·The British Journal of Surgery·L FilgueiraM Heberer
Mar 1, 1994·International Journal of Cancer. Journal International Du Cancer·Q ChenP Hersey
Aug 19, 1993·International Journal of Cancer. Journal International Du Cancer·G A GastlN H Bander
Jan 21, 1993·Nature·X Van OstadeW Fiers
Aug 1, 1993·International Journal of Immunopharmacology·R HiraiK Nomoto
Nov 21, 1997·Clinical and Experimental Immunology·T KucharzikR Stoll
Jan 13, 1998·Journal of Surgical Oncology·L GianottiV Di Carlo

❮ Previous
Next ❯

Citations

May 1, 2008·Environmental Toxicology and Pharmacology·Amr A FouadWafaey Gomaa
Jun 5, 2003·Technology in Cancer Research & Treatment·Ludmila Müller, Graham Pawelec
Sep 1, 2005·Cancer Immunology, Immunotherapy : CII·Junichi SakamotoUNKNOWN Meta-Analysis Group of the Japanese Society for Cancer of the Colon Rectum
Jul 14, 2012·Fukushima Journal of Medical Science·Izumi NakamuraHitoshi Ohto

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.